Chromosome-based platforms
a technology of chromosomes and platforms, applied in the field of chromosome-based platforms, can solve the problems of time-consuming and tedious processes
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
example 2
[0309] A. Construction of Targeting Vector and Transfection into LMtk-Cells for the Generation of Platform Chromosomes
[0310] A targeting vector derived from the vector pWE15 (GeneBank Accession # X65279) was modified by replacing the SalI (Klenow filled) / SmaI neomycin resistance containing fragment with the PvuII / BamHI (Klenow filled) puromycin resistance containing fragment (isolated from plasmid pPUR, Clontech Laboratories, Inc. Palo Alto, Calif.; SEQ ID No. 30) resulting in plasmid pWEPuro. Subsequently a 9 Kb NotI fragment from the plasmid pFK161 (SEQ ID NO: 118) containing a portion of the mouse rDNA region was cloned into the NotI site of pWEPuro resulting in plasmid pWEPuro9K (FIG. 2). The vector pWEPuro9K was digested with Spel to linearize and transfected into LMtk− mouse cells. Puromycin resistant colonies were isolated and subsequently tested for artificial chromosome formation via fluorescent in situ hybridization (FISH) (using mouse major and minor DNA repeat sequences...
example 3
Construction of Targeting Vector and Transfection into LMtk− Cells for the Generation of Platform Chromosomes Containing Multiple Site-Specific Recombination Sites
[0325] An example of a selectable marker system for the creation of a chromosome-based platform is shown in FIG. 4. This system includes a vector containing the SV40 early promoter immediately followed by (1) a 282 base pair (bp) sequence containing the bacteriophage lambda attP site and (2) the puromycin resistance marker. Initially a PvuII / StuI fragment containing the SV40 early promoter from plasmid pPUR (Clontech Laboratories, Inc., Palo Alto, Calif.; Seq ID No. 30) was subcloned into the EcoRI / CRI site of pNEB 193 (a PUC 19 derivative obtained from New England Biolabs, Beverly, Mass.; SEQ ID No. 32) generating the plasmid pSV40193. The only differences between pUC19 and pNEB193 are in the polylinker region. A unique AscI site (GGCGCGCC) is located between the BamHI site and the SmaI site, a unique PacI site (TTAATTA...
example 4
Lambda Integrase Mediated Site-Specific Recombination of a RFP Expressing Vector onto Artificial Chromosomes
[0329] In this example, a vector expressing the red fluorescent protein (RFP) was produced and recombined into the attP site residing on an artificial chromosome within LMTK− cells. This recombination is depicted in FIG. 7.
[0330] A. Construction of Expression Vectors Containing Wildtype and Mutant Lambda Integrase
[0331] Mutations at the glutamic acid at position 174 in the lambda integrase protein relaxes the requirement for the accessory protein IHF during recombination and DNA supercoiling in vitro (see, Miller et al. (1980) Cell 20:721-729; Lange-Gustafson et al. (1984) J. Biol. Chem. 259:12724-12732). Mutations at this site promote attP, attB intramolecular recombination in mammalian cells (Lorbach et al. (2000) J. Mol. Biol 296:1175-1181).
[0332] To construct nucleic acid encoding the mutant, lambda integrase was PCR amplified from bacteriophage lambda DNA (cI857 ind ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


